Citation: K. Liu et al., MORPHOLOGIC CRITERIA FOR THE PRELIMINARY IDENTIFICATION OF FUSARIUM, PAECILOMYCES, AND ACREMONIUM SPECIES BY HISTOPATHOLOGY, AJCP. American journal of clinical pathology, 109(1), 1998, pp. 45-54
Citation: Ja. Alspaugh et al., SIGNAL-TRANSDUCTION PATHWAYS REGULATING DIFFERENTIATION AND PATHOGENICITY OF CRYPTOCOCCUS-NEOFORMANS, Fungal genetics and biology (Print), 25(1), 1998, pp. 1-14
Authors:
WALSH TJ
HIEMENZ JW
SEIBEL NL
PERFECT JR
HORWITH G
LEE L
SILBER JL
DINUBILE MJ
REBOLI A
BOW E
LISTER J
ANAISSIE EJ
Citation: Tj. Walsh et al., AMPHOTERICIN-B LIPID COMPLEX FOR INVASIVE FUNGAL-INFECTIONS - ANALYSIS OF SAFETY AND EFFICACY IN 556 CASES, Clinical infectious diseases, 26(6), 1998, pp. 1383-1396
Authors:
PALMER SM
PERFECT JR
HOWELL DN
LAWRENCE CM
MIRALLES AP
DAVIS RD
TAPSON VF
Citation: Sm. Palmer et al., CANDIDAL ANASTOMOTIC INFECTION IN LUNG-TRANSPLANT RECIPIENTS - SUCCESSFUL TREATMENT WITH A COMBINATION OF SYSTEMIC AND INHALED ANTIFUNGAL AGENTS, The Journal of heart and lung transplantation, 17(10), 1998, pp. 1029-1033
Citation: Md. Johnson et al., CHEST DISCOMFORT ASSOCIATED WITH LIPOSOMAL AMPHOTERICIN-B - REPORT OF3 CASES AND REVIEW OF THE LITERATURE, Pharmacotherapy, 18(5), 1998, pp. 1053-1061
Authors:
DELPOETA M
SCHELL WA
DYKSTRA CC
JONES S
TIDWELL RR
CZARNY A
BAJIC M
BAJIC M
KUMAR A
BOYKIN D
PERFECT JR
Citation: M. Delpoeta et al., STRUCTURE IN-VITRO ACTIVITY RELATIONSHIPS OF PENTAMIDINE ANALOGS AND DICATION-SUBSTITUTED BIS-BENZIMIDAZOLES AS NEW ANTIFUNGAL AGENTS, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2495-2502
Authors:
DELPOETA M
SCHELL WA
DYKSTRA CC
JONES SK
TIDWELL RR
KUMAR A
BOYKIN DW
PERFECT JR
Citation: M. Delpoeta et al., IN-VITRO ANTIFUNGAL ACTIVITIES OF A SERIES OF DICATION-SUBSTITUTED CARBAZOLES, FURANS, AND BENZIMIDAZOLES, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2503-2510
Authors:
SCHELL WA
DEALMEIDA GMD
DODGE RK
OKONOGI K
PERFECT JR
Citation: Wa. Schell et al., IN-VITRO AND IN-VIVO EFFICACY OF THE TRIAZOLE TAK-187 AGAINST CRYPTOCOCCUS-NEOFORMANS, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2630-2632
Authors:
FIRESTINE SM
MISIALEK S
TOFFALETTI DL
KLEM TJ
PERFECT JR
DAVISSON VJ
Citation: Sm. Firestine et al., BIOCHEMICAL ROLE OF THE CRYPTOCOCCUS-NEOFORMANS ADE2 PROTEIN IN FUNGAL DE-NOVO PURINE BIOSYNTHESIS, Archives of biochemistry and biophysics, 351(1), 1998, pp. 123-134
Citation: Ja. Alspaugh et Jr. Perfect, INFECTIONS DUE TO ZYGOMYCETES AND OTHER RARE FUNGAL OPPORTUNISTS, Seminars in respiratory and critical care medicine, 18(3), 1997, pp. 265-279
Citation: Ja. Alspaugh et al., CRYPTOCOCCUS-NEOFORMANS MATING AND VIRULENCE ARE REGULATED BY THE G-PROTEIN ALPHA-SUBUNIT GPA1 AND CAMP, Genes & development, 11(23), 1997, pp. 3206-3217
Citation: Dl. Toffaletti et Jr. Perfect, STUDY OF CRYPTOCOCCUS-NEOFORMANS ACTIN GENE-REGULATION WITH A BETA-GALACTOSIDASE-ACTIN FUSION, Journal of medical and veterinary mycology, 35(5), 1997, pp. 313-320
Citation: M. Delpoeta et al., IN-VITRO ANTIFUNGAL ACTIVITY OF PNEUMOCANDIN L-743,872 AGAINST A VARIETY OF CLINICALLY IMPORTANT MOLDS, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1835-1836
Citation: Bd. Alexander et Jr. Perfect, ANTIFUNGAL RESISTANCE TRENDS TOWARDS THE YEAR 2000 - IMPLICATIONS FORTHERAPY AND NEW APPROACHES, Drugs, 54(5), 1997, pp. 657-678
Authors:
KAUFFMAN CA
PAPPAS PG
MCKINSEY DS
GREENFIELD RA
PERFECT JR
CLOUD GA
THOMAS CJ
DISMUKES WE
NEWMAN C
POWDERLY W
SCHELD M
SHARKEYMATHIS PK
CHAPMAN S
HAMILL R
LARSON R
Citation: Ca. Kauffman et al., TREATMENT OF LYMPHOCUTANEOUS AND VISCERAL SPOROTRICHOSIS WITH FLUCONAZOLE, Clinical infectious diseases, 22(1), 1996, pp. 46-50
Citation: Re. Fuller et al., TREATMENT OF VANCOMYCIN-RESISTANT ENTEROCOCCI, WITH A FOCUS ON QUINUPRISTIN-DALFOPRISTIN, Pharmacotherapy, 16(4), 1996, pp. 584-592
Citation: Gm. Cox et al., DOMINANT SELECTION SYSTEM FOR USE IN CRYPTOCOCCUS-NEOFORMANS, Journal of medical and veterinary mycology, 34(6), 1996, pp. 385-391
Citation: Wa. Schell et Jr. Perfect, FATAL, DISSEMINATED ACREMONIUM-STRICTUM INFECTION IN A NEUTROPENIC HOST, Journal of clinical microbiology, 34(5), 1996, pp. 1333-1336
Citation: Jr. Perfect et al., IN-VITRO AND IN-VIVO EFFICACIES OF THE AZOLE SCH56592 AGAINST CRYPTOCOCCUS-NEOFORMANS, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1910-1913
Citation: Jr. Perfect, FUNGAL VIRULENCE GENES AS TARGETS FOR ANTIFUNGAL CHEMOTHERAPY, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1577-1583